GetTopicDetailResponse(id=d61d32384ef, topicName=制藥, introduction=制藥, content=null, image=null, comments=1, allHits=1652, url=https://h5.medsci.cn/topic?id=32384, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=12280, tagList=[TagDto(tagId=12280, tagName=制藥)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=903591, encodeId=2e9c903591b5, content=<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a> <a href='/topic/show?id=d61d32384ef' target=_blank style='color:#2F92EE;'>#制藥#</a> 日本制藥公司Sosei早在4月就啟動了研發(fā)計劃，旨在設(shè)計和開發(fā)針對SARS-CoV-2病毒的新型藥物。, objectTitle=日本制藥公司Sosei Heptares發(fā)現(xiàn)或可治療COVID-19的小分子, objectType=article, longId=203880, objectId=b33b203880a7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201129/1606619667864_5295902.jpeg, objectUrl=/article/show_article.do?id=b33b203880a7, replyNumber=0, likeNumber=240, createdTime=2020-11-30, rootId=0, userName=BJying, userId=fb825296401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b33b203880a7, moduleTitle=日本制藥公司Sosei Heptares發(fā)現(xiàn)或可治療COVID-19的小分子, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b33b203880a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
